Shattuck Labs, Inc. (STTK) vs Valneva SE Sponsored ADR (VALN)

Shattuck Labs, Inc. and Valneva SE Sponsored ADR are both Biotechnology companies. Shattuck Labs, Inc. and Valneva SE Sponsored ADR are of similar size ($560.4M and $555.0M). Shattuck Labs, Inc. has negative trailing earnings, so its P/E is not meaningful; Valneva SE Sponsored ADR trades at 59.7×. Shattuck Labs, Inc. grew revenue faster over the last twelve months: 106.5% against −53.2%. Shattuck Labs, Inc. has the higher net margin (0.00% vs −12.0%) and the lower return on invested capital (−1,230.7% vs 0.00%). Across the 17 metrics below, Valneva SE Sponsored ADR leads on 9 and Shattuck Labs, Inc. on 8.

Valuation

Metric STTK VALN Biotechnology median
P/E n/m 59.68 8.50
P/S 125.47 3.05 9.71
P/B 3.33 5.30 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 42.91 0.64
EV/Sales 88.32 3.49 9.21
Earnings yield (9.41%) 1.68% (33.15%)
Free cash flow yield (5.86%) (11.78%) (25.50%)

Profitability

Metric STTK VALN Biotechnology median
Gross margin 100.00% 38.28% 65.16%
Operating margin 0.00% 13.56% 0.00%
Net margin 0.00% (12.01%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (39.21%) 0.00% (56.36%)
Return on assets (36.88%) 0.00% (48.04%)
Return on invested capital (1,230.74%) 0.00% 0.00%

Growth

Metric STTK VALN Biotechnology median
Revenue growth (TTM) 106.48% (53.16%) 6.02%
EPS growth (last fiscal year) 53.02% (805.88%) 30.26%
Revenue growth, 5-year CAGR (36.82%) 9.41% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric STTK VALN Biotechnology median
Debt to equity 0.00 2.27 0.00
Current ratio 27.59 2.16 4.72
Net debt to EBITDA 1.62 (1.15) 0.96

Dividend

Metric STTK VALN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric STTK VALN Biotechnology median
Market cap 555.01m 560.39m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack